Brian E Perron1, Kipling Bohnert2,3, Angela K Perone1, Marcel O Bonn-Miller4,5,6,7, Mark Ilgen2,3. 1. School of Social Work, University of Michigan, Ann Arbor, Michigan. 2. Veterans Affairs (VA) Serious Mental Illness Treatment Resource and Evaluation Center (SMITREC), Department of Veterans Affairs Healthcare System, Ann Arbor, Michigan. 3. Department of Psychiatry, University of Michigan, Ann Arbor, Michigan. 4. Center of Excellence in Substance Abuse Treatment and Education, Philadelphia VA Medical Center, Philadelphia, Pennsylvania. 5. National Center for PTSD, VA Palo Alto Health Care System, Palo Alto, California. 6. Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, California. 7. Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Abstract
OBJECTIVE: Management of chronic pain is one of the most common reasons given by individuals seeking medical cannabis. However, very little information exists about the concurrent use of cannabis and prescription pain medication (PPM). This study fills this gap in knowledge by systematically comparing medical cannabis users who use or do not use PPM, with an emphasis on understanding whether concurrent use of cannabis and PPM is associated with more serious forms of alcohol and other drug involvement. METHOD: Data from this study were collected from a medical cannabis clinic in southwestern Michigan (N = 273). Systematic comparisons were made on measures of sociodemographics, reasons for substance use, pain, functioning, and perceptions of PPM and medical cannabis efficacy. RESULTS: PPM users tended to be older and reported higher levels of pain and lower levels of functioning. The overall sample exhibited higher lifetime and past-3-month rates of alcohol and other noncannabis drug use than did the general population. Approximately 40% of subjects reported combining cannabis with alcohol, but no significant difference was observed between PPM users and nonusers. PPM users and nonusers did not exhibit any difference in either lifetime or past-3-month use of other drugs, including cocaine, sedatives, street opioids, and amphetamines. PPM users rated the efficacy of cannabis higher than PPM for pain management and indicated a strong desire to reduce PPM usage. CONCLUSIONS: Use of PPM among medical cannabis users was not identified as a correlate for more serious forms of alcohol and other drug involvement. However, longitudinal study designs are needed to better understand the trajectories of alcohol and other drug involvement over time among medical cannabis users.
OBJECTIVE: Management of chronic pain is one of the most common reasons given by individuals seeking medical cannabis. However, very little information exists about the concurrent use of cannabis and prescription pain medication (PPM). This study fills this gap in knowledge by systematically comparing medical cannabis users who use or do not use PPM, with an emphasis on understanding whether concurrent use of cannabis and PPM is associated with more serious forms of alcohol and other drug involvement. METHOD: Data from this study were collected from a medical cannabis clinic in southwestern Michigan (N = 273). Systematic comparisons were made on measures of sociodemographics, reasons for substance use, pain, functioning, and perceptions of PPM and medical cannabis efficacy. RESULTS: PPM users tended to be older and reported higher levels of pain and lower levels of functioning. The overall sample exhibited higher lifetime and past-3-month rates of alcohol and other noncannabis drug use than did the general population. Approximately 40% of subjects reported combining cannabis with alcohol, but no significant difference was observed between PPM users and nonusers. PPM users and nonusers did not exhibit any difference in either lifetime or past-3-month use of other drugs, including cocaine, sedatives, street opioids, and amphetamines. PPM users rated the efficacy of cannabis higher than PPM for pain management and indicated a strong desire to reduce PPM usage. CONCLUSIONS: Use of PPM among medical cannabis users was not identified as a correlate for more serious forms of alcohol and other drug involvement. However, longitudinal study designs are needed to better understand the trajectories of alcohol and other drug involvement over time among medical cannabis users.
Authors: Nicholas A Swartzwelder; M Louise Risher; Sabri H Abdelwahab; Anouska D'Abo; Amir H Rezvani; Edward D Levin; Wilkie A Wilson; H Scott Swartzwelder; Shawn K Acheson Journal: Neurosci Lett Date: 2012-08-29 Impact factor: 3.046
Authors: Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison Journal: Pain Date: 2007-05-09 Impact factor: 6.961
Authors: Lynn E Fiellin; Jeanette M Tetrault; William C Becker; David A Fiellin; Rani A Hoff Journal: J Adolesc Health Date: 2012-08-20 Impact factor: 5.012
Authors: Mark A Ilgen; Kipling Bohnert; Felicia Kleinberg; Mary Jannausch; Amy S B Bohnert; Maureen Walton; Frederic C Blow Journal: Drug Alcohol Depend Date: 2013-05-15 Impact factor: 4.492
Authors: Shaness A Grenald; Madison A Young; Yue Wang; Michael H Ossipov; Mohab M Ibrahim; Tally M Largent-Milnes; Todd W Vanderah Journal: Neuropharmacology Date: 2016-12-20 Impact factor: 5.250
Authors: Shannon M Nugent; Bobbi Jo Yarborough; Ning X Smith; Steven K Dobscha; Richard A Deyo; Carla A Green; Benjamin J Morasco Journal: Gen Hosp Psychiatry Date: 2017-11-08 Impact factor: 3.238
Authors: Vishakh Iyer; Richard A Slivicki; Ana C Thomaz; Jonathon D Crystal; Ken Mackie; Andrea G Hohmann Journal: Eur J Pharmacol Date: 2020-09-05 Impact factor: 4.432
Authors: Jenna McAfee; Kevin F Boehnke; Stephanie M Moser; Chad M Brummett; Jennifer F Waljee; Erin E Bonar Journal: Reg Anesth Pain Med Date: 2020-11-18 Impact factor: 6.288